CA3283846A1 - Anticorps bispécifiques agonistes de 4-1bb dépendant de ceacam5 - Google Patents

Anticorps bispécifiques agonistes de 4-1bb dépendant de ceacam5

Info

Publication number
CA3283846A1
CA3283846A1 CA3283846A CA3283846A CA3283846A1 CA 3283846 A1 CA3283846 A1 CA 3283846A1 CA 3283846 A CA3283846 A CA 3283846A CA 3283846 A CA3283846 A CA 3283846A CA 3283846 A1 CA3283846 A1 CA 3283846A1
Authority
CA
Canada
Prior art keywords
ceacam5
dependent
bispecific antibodies
agonistic
agonistic bispecific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3283846A
Other languages
English (en)
Inventor
Runsheng Li
Wei Cao
Ying Qin ZANG
Wentao Huang
Original Assignee
Lanova Medicines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanova Medicines Ltd filed Critical Lanova Medicines Ltd
Publication of CA3283846A1 publication Critical patent/CA3283846A1/fr
Pending legal-status Critical Current

Links

CA3283846A 2023-02-28 2024-02-28 Anticorps bispécifiques agonistes de 4-1bb dépendant de ceacam5 Pending CA3283846A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNPCT/CN2023/078788 2023-02-28

Publications (1)

Publication Number Publication Date
CA3283846A1 true CA3283846A1 (fr) 2024-09-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP4303231A4 (fr) Anticorps bispécifique
EP4159764A4 (fr) Anticorps bispécifique anti-pdl1 × egfr
EP3978015A4 (fr) Anticorps bispécifique
CA3268389A1 (fr) Anticorps anti-ccr8
CA3265092A1 (fr) Anticorps anti-nectine-4 humanisés
CA3246035A1 (fr) Anticorps anti-par2
CA3288182A1 (fr) Anticorps bispécifiques à charnière modifiée
CA3283846A1 (fr) Anticorps bispécifiques agonistes de 4-1bb dépendant de ceacam5
CA3265265A1 (fr) Anticorps bispécifique
HK40097035A (en) Bispecific antibody
CA3270337A1 (fr) Composés d'anticorps bispécifiques
CA3297530A1 (fr) Anticorps anti-trop2
CA3291410A1 (fr) Anticorps anti-fibrilles
AU2024304161A1 (en) Anti-fibril antibodies
AU2024273407A1 (en) Anti-cathepsin-d antibodies
CA3292361A1 (fr) Anticorps anti-cathepsine d
CA3291266A1 (fr) Anticorps anti-il1rap
HK40130657A (en) Antibodies
CA3276655A1 (fr) Anticorps
CA3279302A1 (fr) Anticorps anti-unc5c
HK40128850A (en) Anti-unc5c antibodies
CA3279198A1 (fr) Anticorps anti-il-18bp
CA3271432A1 (fr) Anticorps anti-bêta-caténine
HK40130590A (en) Anti-beta-catenin antibodies
HK40115462A (en) Anti-par2 antibodies